alexa Ankita Garg | University of California
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Ankita Garg

Ankita Garg Executive Editor
Ankita Garg
Department of Pediatrics
University of California
USA
Tel:+1-(903) 363-5988.
Biography

Dr Ankita Garg is in School of Medicine at University of California San Diego and investigating the role of myeloid derived suppressor cells mediated immune suppression in HIV-1 infection. She earned Ph.D. from SGPGIMS, India for her work on understanding molecular mechanism of Ethambutol resistance in Mycobacterium tuberculosis and immune pathogenesis of ethambutol resistant M tuberculosis strain. During postdoctoral research at UTHCT Texas, Dr Garg studied the role of natural killer and regulatory T cells in M tuberculosis infection. She has served as Senior Research Scientist in R&D Division of Panacea Biotec and Lupin Ltd, two well-established drug discovery and development organizations. She was responsible for rationalized selection of targets and enriching the discovery pipeline including drug discovery, in-vitro and in-vivo assays, cross-functions such as DMPK, toxicology for diverse therapeutic areas. Dr Garg has over nine years of experience in translational research pertaining to infectious disease and immune disorders.

Research Interest

Mycobacterium tuberculosis, immune dysfunction in HIV-AIDS and associated co infections, cellular and clinical immunology, translational immunology, biomarkers, vaccine research

Certificate
Certificate

Publications

Releasing the Brakes in Cancer
Shweta Dubey* and Ankita Garg*
Review Article: J Bioanal Biomed 2016 8: 17
DOI: 10.4172/1948-593X.1000147
 

Journal of Bioanalysis & Biomedicine - Immunoprophylaxix


Dr Ankita Garg is in School of Medicine at University of California San Diego and investigating the role of myeloid derived suppressor cells mediated immune suppression in HIV-1 infection. She earned Ph.D. from SGPGIMS, India for her work on understanding molecular mechanism of Ethambutol resistance in Mycobacterium tuberculosis and immune pathogenesis of ethambutol resistant M tuberculosis strain. During postdoctoral research at UTHCT Texas, Dr Garg studied the role of natural killer and regulatory T cells in M tuberculosis infection. She has served as Senior Research Scientist in R&D Division of Panacea Biotec and Lupin Ltd, two well-established drug discovery and development organizations. She was responsible for rationalized selection of targets and enriching the discovery pipeline including drug discovery, in-vitro and in-vivo assays, cross-functions such as DMPK, toxicology for diverse therapeutic areas. Dr Garg has over nine years of experience in translational research pertaining to infectious disease and immune disorders.

 
Download PPT PPT Views: 219 Updated on: 2015-10-13 For Recent Update: Click here
 
 
Download PDF   PDF Views: 219  Updated on: 2015-10-13 For Recent Update: Click here
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords